Anti-angiogenic cues from vascular basement membrane collagen

Cancer Research

Volumn 60, Issue 9, 2000, Pages 2520-2526

  Colorado, Pablo C ^a   Torre, Adriana ^a   Kamphaus, George ^a   Maeshima, Yohei ^a   Hopfer, Helmut ^a   Takahashi, Keiko ^a   Volk, Ruediger ^a   Zamborsky, Eric D ^a   Herman, Seth ^a   Sarkar, Pradip K ^a   Ericksen, Mark B ^a   Dhanabal, Mohanraj ^a   Simons, Michael ^a   Post, Mark ^a   Kufe, Donald W ^a   Weichselbaum, Ralph R ^b   Sukhatme, Vikas P ^a   Kalluri, Raghu ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BASEMENT MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; COLLAGEN METABOLISM; CONFORMATIONAL TRANSITION; EXTRACELLULAR MATRIX; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; WOUND HEALING;

ANIMALS; ARRESTIN; BASEMENT MEMBRANE; CELL CYCLE; CELL LINE; COLLAGEN; COLLAGEN TYPE XVIII; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; ENDOSTATINS; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; IMMUNOHISTOCHEMISTRY; KINETICS; LAMININ; MICE; MICE, INBRED C57BL; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE FRAGMENTS; PLACENTA; PLASMIDS; PROTEIN STRUCTURE, TERTIARY; PROTEOGLYCANS; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED;

EID: 0034194237     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Kumar, R., Kuniyasu, H., Bucana, C. D., Wilson, M. R., and Fidler, I. J. Spatial and temporal expression of angiogenic molecules during tumor growth and progression. Oncol. Res., 10: 301-311, 1998.
2. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., 1: 27-31, 1995.
3. Holash, J., Wiegand, S. J., and Yancopoulos, G. D. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene, 18: 5356-5362, 1999.
4. Okada, F., Rak, J. W., Croix, B. S., Lieubeau, B., Kaya, M., Roncari, L., Shirasawa, S., Sasazuki, T., and Kerbel, R. S. Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells. Proc. Natl. Acad. Sci. USA, 95: 3609-3614, 1998.
5. Madri, J. A. Extracellular matrix modulation of vascular cell behaviour. Transpl. Immunol., 5: 179-183, 1997.
6. Timpl, R. Macromolecular organization of basement membranes. Curr Opin Cell Biol., 8: 618-624, 1996.
7. Prockop, D. J., and Kivirikko, K. I. Collagens: molecular biology, diseases, and potentials for therapy. Annu. Rev. Biochem., 64: 403-434, 1995.
8. Paulsson, M. Basement membrane proteins: structure, assembly, and cellular interactions. Crit. Rev. Biochem. Mol. Biol., 27: 93-127, 1992.
9. Kalluri, R., Shield, C. F., Todd, P., Hudson, B. G., and Neilson, E. G. Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis. J. Clin. Invest., 99: 2470-2478, 1997.
10. Maragoudakis, M. E., Missirlis, E., Karakiulakis, G. D., Sarmonica, M., Bastakis, M., and Tsopanoglou, N. Basement membrane biosynthesis as a target for developing inhibitors of angiogenesis with anti-tumor properties. Kidney Int., 43: 147-150, 1993.
11. Zhang, X., Hudson, B. G., and Sarras, M. P., Jr. Hydra cell aggregate development is blocked by selective fragments of fibronectin and type IV collagen. Dev. Biol., 164: 10-23, 1994.
12. Tsilibary, E. C., Reger, L. A., Vogel, A. M., Koliakos, G. G., Anderson, S. S., Charonis, A. S., Alegre, J. N., and Furcht, L. T. Identification of a multifunctional, cell-binding peptide sequence from the al(NCl) of type IV collagen. J. Cell Biol., 111: 1583-1591, 1990.
13. Kamphaus, G. D., Colorado, P. C., Panka, D. J., Hopfer, H., Ramchandran, R., Torre, A., Maeshima, Y., Mier, J. W., Sukhatme, V. P., and Kalluri, R. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem., 275: 1209-1215, 2000.
14. Neilson, E. G., Kalluri, R., Sun, M. J., Gunwar, S., Danoff, T., Mariyama, M., Myers, J. C., Reeders, S. T., and Hudson, B. G. Specificity of Goodpasture autoantibodies for the recombinant noncollagenous domains of human type IV collagen. J. Biol. Chem., 268: 8402-8405, 1993.
15. Dhanabal, M., Ramchandran, R., Volk, R., Stillman, I. E., Lombardo, M., Iruela-Arispe, M. L., Simons, M., and Sukhatme, V. P. Endostatin: yeast production, mutants, and antitumor effect in renal cell carcinoma. Cancer Res., 59: 189-197, 1999.
16. Dhanabal, M., Volk, R., Ramchandran, R., Simons, M., and Sukhatme, V. P. Cloning, expression, and in vitro activity of human endostatin. Biochem. Biophys. Res. Commun., 258: 345-352, 1999.
17. Grant, D. S., Kibbey, M. C., Kinsella, J. L., Cid, M. C., and Kleinman, H. K. The role of basement membrane in angiogenesis and tumor growth. Pathol. Res. Pract., 190: 854-863, 1994.
18. O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., and Folkman, J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 88: 277-285, 1997.
19. Sarkar, P. K., and Ray, A. K. Specific binding of L-triiodothyronine modulates Na(+)-K(+)-ATPase activity in adult rat cerebrocortical synaptosomes. Neuroreport, 9: 1149-1152, 1998.
20. Haralabopoulos, G. C., Grant, D. S., Kleinman, H. K., Lelkes, P. I., Papaioannou, S. P., and Maragoudakis, M. E. Inhibitors of basement membrane collagen synthesis prevent endothelial cell alignment in matrigel in vitro and angiogenesis in vivo. Lab. Invest., 71: 575-582, 1994.
21. Passaniti, A., Taylor, R. M., Pili, R., Guo, Y., Long, P. V., Haney, J. A., Pauly, R. R., Grant, D. S., and Martin, G. R. A simple, quantitative method for assessing angiogenesis and anti-angiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest., 67: 519-528, 1992.
22. Gong, J., Chen, D., Kashiwaba, M., and Kufe, D. Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells. Nat. Med., 3: 558-561, 1997.
23. Keller, K. M., Keller, J. M., and Kuhn, K. The C-terminus of type 1 collagen is a major binding site for heparin. Biochim. Biophys. Acta, 882: 1-5, 1986.
24. Senger, D. R., Claffey, K. P., Benes, J. E., Perruzzi, C. A., Sergiou, A. P., and Detmar, M. Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. Proc. Natl. Acad. Sci. USA, 94: 13612-13617, 1997.
25. Bloch, W., Forsberg, E., Lentini, S., Brakebusch, C., Martin, K., Krell, H. W., Weidle, U. H., Addicks, K., and Fassler, R. Beta 1 integrin is essential for teratoma growth and angiogenesis. J. Cell Biol., 139: 265-278, 1997.
26. Pozzi, A., Wary, K. K., Giancotti, F. G., and Gardner, H. A. Integrin alpha1beta1 mediates a unique collagen-dependent proliferation pathway in vivo. J. Cell Biol., 142: 587-594, 1998.
27. Pozzi, A., Moberg, P., Miles, L., Wagner, S., Soloway, P., and Gardner, H. Elevated matrix metalloprotease and angiostatin levels in integrin α1 knockout mice cause reduced tumor vascularization, Proc. Natl. Acad. Sci. USA, 97: 2202-2207, 2000.
28. Moses, M. A., Wiederschain, D., Wu, I., Fernandez, C. A., Ghazizadeh, V., Lane, W. S., Flynn, E., Sytkowski, A., Tao, T., and Langer, R. Troponin I is present in human cartilage and inhibits angiogenesis. Proc. Natl. Acad. Sci. USA, 96: 2645-2650, 1999.
29. Pike, S. E., Yao, L., Jones, K. D., Cherney, B., Appella, E., Sakaguchi, K., Nakhasi, H., Teruya-Feldstein, J., Wirth, P., Gupta, G., and Tosato, G. Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth. J. Exp. Med., 188: 2349-2356, 1998.
30. Dawson, D. W., Volpert, O. V., Gillis, P., Crawford, S. E., Xu, H., Benedict, W., and Bouck, N. P. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science (Washington DC), 285: 245-248, 1999.